Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4666 |  NCEL NewcelX Ltd. - Ordinary Shares | 3.33 USD | +2.15% | -0.60% | -10.00% | -34.45% | 15.98 M USD | ||
| 4668 |  CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.17 USD | +0.46% | +13.61% | +55.00% | +46.62% | 15.61 M USD | ||
| 4671 |  TPST Tempest Therapeutics, Inc. - Common Stock | 1.03 USD | -0.96% | -5.50% | +13.19% | -56.90% | 15.25 M USD | ||
| 4673 |  BCDA BioCardia, Inc. - Common Stock | 1.02 USD | +0.99% | +8.51% | +13.33% | -12.07% | 15.44 M USD | ||
| 4677 |  AKTX Akari Therapeutics Plc - American Depositary Shares | 7.77 USD | 0.00% | -1.27% | -18.04% | +735.48% | 15.13 M USD | ||
| 4683 |  ICU SeaStar Medical Holding Corporation - Common Stock | 3.40 USD | +1.49% | +6.58% | -11.23% | +38.21% | 14.98 M USD | ||
| 4684 |  BIVI BioVie Inc. - Common stock | 1.86 USD | -4.62% | +47.62% | +36.76% | +47.62% | 14.03 M USD | ||
| 4693 |  PASG Passage Bio, Inc. - Common Stock | 4.39 USD | -1.13% | -1.13% | -8.92% | -50.34% | 14.13 M USD | ||
| 4700 |  LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 USD | +27.74% | +70.69% | +23.75% | -21.12% | 17.84 M USD | ||
| 4701 |  PHIO Phio Pharmaceuticals Corp. - Common Stock | 1.17 USD | -0.85% | +9.35% | +10.38% | -1.68% | 13.59 M USD | ||
| 4714 |  GTBP GT Biopharma, Inc. - Common Stock | 0.29 USD | 0.00% | 0.00% | -12.12% | -73.87% | 13.08 M USD | ||
| 4721 |  INAB IN8bio, Inc. - Common Stock | 1.29 USD | +0.78% | +21.70% | +4.88% | -22.75% | 12.72 M USD | ||
| 4725 |  DARE Dare Bioscience, Inc. - Common Stock | 0.81 USD | -1.22% | -8.99% | -36.72% | -50.91% | 12.38 M USD | ||
| 4727 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 0.37 USD | -2.63% | -19.57% | -40.32% | -67.83% | 12.05 M USD | ||
| 4729 |  PDSB PDS Biotechnology Corporation - Common Stock | 0.21 USD | -4.55% | -4.55% | -69.57% | -83.20% | 11.75 M USD | ||
| 4731 |  BLRX BioLineRx Ltd - American Depositary Shares | 2.89 USD | +2.85% | +1.05% | +1.76% | +2.85% | 12.58 M USD | ||
| 4733 |  GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.98 USD | -4.85% | +3.16% | +3.16% | -47.59% | 11.59 M USD | ||
| 4735 |  SNTI Senti Biosciences, Inc. - Common Stock | 0.35 USD | -10.26% | -16.67% | -12.50% | -63.16% | 10.90 M USD | ||
| 4745 |  KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.65 USD | -0.38% | +3.11% | +6.00% | +26.19% | 11.72 M USD | ||
| 4750 |  MBRX Moleculin Biotech, Inc. - Common Stock | 0.58 USD | -1.69% | -3.33% | -72.90% | -81.59% | 11.30 M USD |
Nachrichten Biotechnology Stocks
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Klinischer Meilenstein ohne Kursschub: Aktie von Monte Rosa Therapeutics unter Druck
Biomea Fusion Aktie mit Kurssprung nach Abschluss der Rekrutierung für Diabetes-Studie
Monte Rosa Aktie fällt nach Start von Phase-2-Studie zu Prostatakrebs
ROUNDUP/Aktien New York: Chipwerte belasten Nasdaq kräftig - Dow leicht im Plus
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
H.C. Wainwright bekräftigt "Buy"-Rating für Biomea Fusion nach Meilenstein in Diabetes-Studie
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |